P1.16-33 Occult Lymph Node Metastases in Early Stage NSCLC Patients: Where Do We Stand Now? A Proposal for a Preoperative Risk Model

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.11-01 Methylation Markers That Correlate With Occult Lymph Node Metastases of NSCLC and a Preliminary Prediction Model

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

Predicting Lymph Node Metastases in Early Rectal Cancer

European Journal of Cancer
Cancer ResearchOncology
2013English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Can We Predict Lymph Node Metastasis by Using Preoperative Markers in Gastric Cancer Patients?

Nowotwory
Cancer ResearchOncology
2019English

Mouse Models for Food Allergies: Where Do We Stand?

Cells
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy